Innovation bottlenecks: Human ‘challenge studies’ that purposefully expose subjects to a virus key to developing effective vaccines and minimizing health and financial risks
The most common bottlenecks in vaccine development are cost, risk, safety and time. A vaccine may show promise in a preclinical or Phase I trial, but if